Home
Categories
EXPLORE
True Crime
Comedy
Society & Culture
Business
Sports
History
Fiction
About Us
Contact Us
Copyright
© 2024 PodJoint
00:00 / 00:00
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts221/v4/77/b6/27/77b62731-cbf4-c23e-55ba-e0a8dd068b79/mza_17279697081413539006.png/600x600bb.jpg
Prostate Cancer Update
Dr. Neil Love
46 episodes
3 days ago
Featuring one-on-one interviews conducted by Dr Neil Love, this series bridges the gap between research and patient care by providing urologists and radiation oncologists ongoing access to the perspectives and opinions of national and international prostate cancer research leaders.
Show more...
Science
Education,
Health & Fitness,
Medicine
RSS
All content for Prostate Cancer Update is the property of Dr. Neil Love and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Featuring one-on-one interviews conducted by Dr Neil Love, this series bridges the gap between research and patient care by providing urologists and radiation oncologists ongoing access to the perspectives and opinions of national and international prostate cancer research leaders.
Show more...
Science
Education,
Health & Fitness,
Medicine
https://artwork.captivate.fm/97635d70-f91b-4542-ac9e-4ad77eab0c7d/HDx77o9GuXjm3JsutW_azrxg.png
Prostate Cancer and AKT Inhibitors — Proceedings from a Session Held During the American Urological Association Annual Meeting
Prostate Cancer Update
1 hour 22 minutes 55 seconds
5 months ago
Prostate Cancer and AKT Inhibitors — Proceedings from a Session Held During the American Urological Association Annual Meeting
Prostate Cancer Update
Featuring one-on-one interviews conducted by Dr Neil Love, this series bridges the gap between research and patient care by providing urologists and radiation oncologists ongoing access to the perspectives and opinions of national and international prostate cancer research leaders.